Domov › Rakovina prsníka › South Carolina

Klinické štúdie Rakovina prsníka v štáte South Carolina

23 štúdií pre Rakovina prsníka hľadá účastníkov v zariadeniach v štáte South Carolina.

Mestá v štáte South Carolina

Oficiálny text štúdie (anglicky)

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Bon Secours St Francis Cancer Center, Greenville

Prebieha náborFáza 3

Vek 18 až 100 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AnMed Health Cancer Center, Anderson
Prisma Health Richland Hospital, Columbia
McLeod Regional Medical Center, Florence
a 12 ďalších

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069

CBD for Breast Cancer Primary Tumors

Medical University of South Carolina, Charleston

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT06148038

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

St. Joseph's Candler Bluffton Campus, Bluffton
SC Cancer Specialists - Hilton Head at St. Joseph's/Candler, Hilton Head Island
Levine Cancer Institute, Rock Hill

Prebieha náborFáza 3

Vek 60 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06377852

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Medical University of South Carolina-Hollings Cancer Center ( Site 0016), Charleston
St Francis Cancer Center ( Site 0093), Greenville

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06966700

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Medical University of South Carolina, Charleston

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07174336

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Hollings Cancer Center, Charleston

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT06492616

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

Spartanburg Regional Healthcare System, Spartanburg

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT05315700

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Bon Secours - St. Francis Hospital, Greenville

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06790693

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Saint Joseph's/Candler - Bluffton Campus, Bluffton
Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
a 14 ďalších

Prebieha náborFáza 3

Vek 18 až 60 · Ženy · Aktualizované 2. 9. 2026 · NCT05879926

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

St Francis Cancer Center, Greenville

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 8. 2026 · NCT06926868

E-Mindfulness Approaches for Living After Breast Cancer

Beaufort Memorial Hospital, Beaufort
Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
a 10 ďalších

Prebieha náborFáza 3

Vek 18 až 50 · Všetky pohlavia · Aktualizované 4. 8. 2026 · NCT06748222

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Medical University of South Carolina, Charleston

Prebieha náborFáza 2

Vek 18 až 55 · Ženy · Aktualizované 27. 7. 2026 · NCT06184750

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

Prisma Health - Upstate (ITOR)_Edenfield ( Site 0053), Greenville

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 5. 2026 · NCT06686394

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Medical University of South Carolina, Charleston

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 4. 2026 · NCT04468061

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Saint Joseph's/Candler - Bluffton Campus, Bluffton
Medical University of South Carolina, Charleston
McLeod Regional Medical Center, Florence
a 5 ďalších

Prebieha náborFáza 3

Vek 50 až 70 · Všetky pohlavia · Aktualizované 23. 4. 2026 · NCT04852887

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

AnMed Health Cancer Center, Anderson
Beaufort Memorial Hospital, Beaufort
Saint Joseph's/Candler - Bluffton Campus, Bluffton
a 18 ďalších

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 3. 2026 · NCT06418204

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Medical University of South Carolina, Charleston
McLeod Health, Florence

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 40 a viac · Všetky pohlavia · Aktualizované 20. 1. 2026 · NCT05366881

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Spartanburg Medical Center, Spartanburg

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 1. 2026 · NCT06401421

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Greenville

Prebieha náborObservačná štúdia

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Prisma Health Cancer Institute - Butternut, Greenville
Prisma Health Cancer Institute - Faris, Greenville
Prisma Health Cancer Institute - Eastside, Greenville

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 10. 2025 · NCT03418961

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Roper St. Francis Physician Partners - Breast Surgery, Charleston
Tidelands Health Coastal Carolina Breast Center, Georgetown

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 8. 2025 · NCT03053193

Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients

Prisma Health Cancer Institute, Greenville

Prebieha náborObservačná štúdia

Vek 20 a viac · Ženy · Aktualizované 4. 11. 2024 · NCT06672497

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.